Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-2320
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma ; day:26 ; month:4 ; year:2021 ; pages:1-7
Neurosurgical review ; (26.4.2021), 1-7
- Urheber
-
Dubinski, Daniel
Won, Sae-Yeon
Voss, Martin
Keil, Fee
Miesbach, Wolfgang
Behmanesh, Bedjan
Dosch, Max
Baumgarten, Peter
Bernstock, Joshua D.
Seifert, Volker
Freiman, Thomas Michael
Geßler, Florian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10143-021-01539-9
- URN
-
urn:nbn:de:101:1-2021061719053197805762
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dubinski, Daniel
- Won, Sae-Yeon
- Voss, Martin
- Keil, Fee
- Miesbach, Wolfgang
- Behmanesh, Bedjan
- Dosch, Max
- Baumgarten, Peter
- Bernstock, Joshua D.
- Seifert, Volker
- Freiman, Thomas Michael
- Geßler, Florian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Heparin and Venous Thrombo-Embolism
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Increased Heparin Clearance in Experimental Pulmonary Embolism
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Heparin and Venous Thrombo-Embolism
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Increased Heparin Clearance in Experimental Pulmonary Embolism
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Heparin and Venous Thrombo-Embolism
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Increased Heparin Clearance in Experimental Pulmonary Embolism
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis